Donald Foley Net Worth
The estimated Net Worth of Donald E Foley is at least $1.7 Million dollars as of 6 March 2018. Mr. Foley owns over 25,000 units of BioSig Technologies stock worth over $1,703,400 and over the last 16 years he sold BSGM stock worth over $0. In addition, he makes $0 as Independent Director at BioSig Technologies.
Mr. Foley BSGM stock SEC Form 4 insider trading
Donald has made over 2 trades of the BioSig Technologies stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 25,000 units of BSGM stock worth $35,500 on 6 March 2018.
The largest trade he’s ever made was buying 200,000 units of BioSig Technologies stock on 18 November 2015 worth over $300,000. On average, Donald trades about 10,227 units every 38 days since 2004. As of 6 March 2018 he still owns at least 255,000 units of BioSig Technologies stock.
You can see the complete history of Mr. Foley stock trades at the bottom of the page.
Donald Foley biography
Donald E. Foley is an Independent Director of the Company. Mr. Foley was chairman of the board and chief executive officer of Wilmington Trust Corporation from 2010-2011. Prior to Wilmington Trust Corporation, Mr. Foley was senior vice president, treasurer and director of tax for ITT Corporation, a supplier of advanced technology products and services. Mr. Foley currently serves on the board of directors of AXA Equitable EQAT Mutual Funds and is an advisory board member of M&T Corporation Trust and Investment Committee. Mr. Foley also served on the boards of directors of M&T Corporation from 2011-2012 and of Wilmington Trust Company, Wilmington Funds and Wilmington Trust Corporation from 2007-2011. In addition, Mr. Foley serves as chairman of the board of trustees of the Burke Rehabilitation Hospital and Burke Medical Research Institute, as well as the W. Burke Foundation since 2009 during which time the Hospital merged with the MonteFiore Hospital System. Mr. Foley holds an M.B.A. from New York University, and a B.A. from Union College where he had served as a trustee, and as a chairman of the President’s Council. He also served as a trustee of the Covent of the Sacred Heart; and currently serves as a trustee at the Sacred Heart Network of schools and chairman of the board at New Beginning Family Academy, a charter school in Bridgeport, CT. Mr. Foley brings extensive financial, economic, capital markets and executive leadership expertise to our board gained through his successful career on Wall Street and the Fortune 500.
How old is Donald Foley?
Donald Foley is 67, he’s been the Independent Director of BioSig Technologies since 2015. There are 1 older and 7 younger executives at BioSig Technologies. The oldest executive at BioSig Technologies, Inc. is Jerome Zeldis, 69, who is the Director.
What’s Donald Foley’s mailing address?
Donald’s mailing address filed with the SEC is C/O BIOSIG TECHNOLOGIES, INC., 54 WILTON ROAD, 2ND FLOOR, WESTPORT, CT, 06880.
Insider trading at BioSig Technologies
Over the last 4 years, insiders at BioSig Technologies have traded over $1,248,337 worth of BioSig Technologies stock and bought 626,440 units worth $1,368,221 . The most active insider traders include Kenneth L Londoner, Asher Holzer, and Jerome B Zeldis. On average, BioSig Technologies executives and independent directors trade stock every 25 days with the average trade being worth of $251,861. The most recent stock trade was executed by Kenneth L Londoner on 7 June 2019, trading 4,650 units of BSGM stock currently worth $29,249.
What does BioSig Technologies do?
BioSig Technologies, Inc. operates as a medical device company. It engages in the development of proprietary biomedical signal processing technology platform to minimize noise and artifacts from cardiac recordings. The company develops and designs the precise uninterrupted real-time evaluation of electrograms electrophysiology (EP) system which acquires, processes, and displays electrocardiogram and electrograms required during EP studies and ablation procedures. BioSig Technologies was founded by Kenneth L. Londoner on February 24, 2009 and is headquartered in Los Angeles, CA.
What does BioSig Technologies’s logo look like?
Complete history of Mr. Foley stock trades at ITT and BioSig Technologies
BioSig Technologies executives and stock owners
BioSig Technologies executives and other stock owners filed with the SEC include:
- Kenneth Londoner, Executive Chairman of the Board, Chief Executive Officer
- Steven Chaussy, Chief Financial Officer
- Martha Pease, Independent Director
- Andrew Ballou, Vice President – Investor Relations
- David Weild, Independent Director
- Samuel Navarro, Independent Director
- Patrick Gallagher, Independent Director
- Donald Foley, Independent Director
- Andrew Filler, Independent Director
- Jerome Zeldis, Director
- Jeffrey O’Donnell, Lead Independent Director
- Julie Stephenson, Senior Director of Clinical Affairs
- Manasi Patwardhan, Director of Strategic Planning
- Olivier Chaudoir, Director of Marketing
- John Kowalski, Vice President of Sales
- Steve Chaussy, Chief Financial Officer
- Roy T Tanaka, Director
- Lora Mikolaitis, 10% owner
- Seth H.Z. Fischer, Director
- Joseph Rafferty, Chief Commercialization Offcr
- Asher Holzer, Director
- Gregory D Cash, President and CEO